Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 July 2007, Vol. 110, No. 2, pp. 479-484.
Prepublished online as a Blood First Edition Paper on March 5, 2007; DOI 10.1182/blood-2006-10-054601.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Appendices
Right arrow All Versions of this Article:
blood-2006-10-054601v1
110/2/479    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y. H.
Right arrow Articles by Hoppe, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y. H.
Right arrow Articles by Hoppe, R. T.
Related Collections
Right arrow Free Research Articles
Right arrow Review Articles
Right arrow Clinical Trials and Observations
Right arrow Neoplasia
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

REVIEW ARTICLE

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Youn H. Kim1, Rein Willemze2, Nicola Pimpinelli3, Sean Whittaker4, Elise A. Olsen5, Annamari Ranki6, Reinhard Dummer7, Richard T. Hoppe, for the ISCL and the EORTC8

1 Department of Dermatology, Stanford Comprehensive Cancer Center, Stanford, CA; 2 Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; 3 Department of Dermatological Sciences, University of Florence, Florence, Italy; 4 Skin Tumour Unit, St. Thomas' Hospital, London, United Kingdom; 5 Department of Medicine, Divisions of Dermatology and Oncology, Duke University Medical Center, Durham, NC; 6 Department of Dermatology and Venereal Diseases, Helsinki University Hospital, Helsinki, Finland; 7 Department of Dermatology, University Hospital Zurich, Zurich, Switzerland; 8 Department of Radiation Oncology, Stanford Comprehensive Cancer Center, Stanford, CA

Currently availabel staging systems for non-Hodgkin lymphomas are not useful for clinical staging classification of most primary cutaneous lymphomas. The tumor, node, metastases (TNM) system used for mycosis fungoides (MF) and Sézary syndrome (SS) is not appropriate for other primary cutaneous lymphomas. A usable, unified staging system would improve the communication about the state of disease, selection of appropriate management, standardization of enrollment/response criteria in clinical trials, and collection/analysis of prospective survival data. Toward this goal, during the recent meetings of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC), the representatives have established a consensus proposal of a TNM classification system applicable for all primary cutaneous lymphomas other than MF and SS. Due to the clinical and pathologic heterogeneity of the cutaneous lymphomas, the currently proposed TNM system is meant to be primarily an anatomic documentation of disease extent and not to be used as a prognostic guide.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
B. F. Chong, A. J. Wilson, H. M. Gibson, M. S. Hafner, Y. Luo, C. J. Hedgcock, and H. K. Wong
Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Clin. Cancer Res., February 1, 2008; 14(3): 646 - 653.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Y. Kim, R. Knobler, H. Zackheim, M. Duvic, T. Estrach, S. Lamberg, et al.
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Blood, September 15, 2007; 110(6): 1713 - 1722.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020